Research finds routine prostate cancer tests may 'do more harm than good'
Routine tests for prostate cancer do not save lives and have the potential to do more harm than good, a study has suggested.
More than 400,000 men were involved in the trial which looked at the efficacy of prostate-specific antigen (PSA) tests - which are available in the UK on request for all men over 50.




